Multiple Choice Identify the
choice that best completes the statement or answers the question.
|
|
1.
|
Both domestic and imported drugs require approval by (a/the) _______________
before they can be marketed in the United States.
A. | FDA | B. | US Marshal | C. | DEA | D. | US Customs |
|
|
2.
|
The _____________________ prohibited interstate commerce in adulterated or
misbranded food, drinks, and drugs.
A. | 1938 Food, Drug and Cosmetic (FDC) Act | B. | Food and Drug Act of 1906 | C. | Harrison
Act | D. | 1990 Omnibus Reconciliation Act |
|
|
3.
|
In response to growing addiction to opiates and cocaine-containing medicines,
the Harrison Narcotic Act of 1914 required that all manufacturers, importers and physicians
prescribing narcotics be
A. | licensed. | B. | taxed. | C. | licensed and
taxed. | D. | fined. |
|
|
4.
|
The Food and Drug Administration was initially named the
A. | Food, Drug, and Alcohol Commission. | B. | Food, Drug and Weapons
Administration. | C. | Food, Drug, and Hazardous Substance Regulatory Agency. | D. | Food, Drug and
Insecticide Administration. |
|
|
5.
|
Because of fatal poisoning from liquid sulfanilamide, the
________________________ required new drugs be shown to be safe before marketing.
A. | Food and Drug Act of 1906 | B. | 1938 Food, Drug, and Cosmetic
Act | C. | 1951 Durham Humphrey Amendment | D. | 1990 Omnibus Budget Reconciliation Act
(OBRA) |
|
|
6.
|
The _____________ required child-proof packaging for most prescription
drugs.
A. | Food, Drug, and Cosmetic Act | B. | Poison Prevention Packaging
Act | C. | Durham-Humphrey Amendment | D. | Kefauver-Harris
Amendment |
|
|
7.
|
The 1984 Hatch-Watchman Act allowed for
A. | quicker introduction of genetic drugs only. | B. | extension of drug
patent terms only. | C. | quicker introduction of drugs and extension of
drug patents. | D. | introduction of generic versions of trade drugs regardless of patent
terms. |
|
|
8.
|
Pharmacists were required to offer counseling to Medicaid patients by the
A. | Durham-Humphrey Amendment. | B. | 1990 Omnibus Budget Reconciliation Act
(OBRA). | C. | Kefauver-Harris Amendment. | D. | Harrison Act. |
|
|
9.
|
Drugs that require prescriptions are _________________ drugs.
A. | Durham | B. | Humphrey | C. | legend | D. | Kefauver |
|
|
10.
|
An inactive substance given in place of a medication during clinical trials is a
A. | pediatric. | B. | phase 2. | C. | phase
3. | D. | placebo. |
|
|
11.
|
The FDA requires ___________________ phases of testing in humans.
|
|
12.
|
The main purpose of phase 2 clinical trials is
A. | dosage. | B. | economics. | C. | animals. | D. | effectiveness. |
|
|
13.
|
Phase 3 clinical trials generally have ____________________ participants.
A. | several hundred to several thousand | B. | 20-100 patients | C. | less than
10 | D. | up to several hundred. |
|
|
14.
|
The Pediatric Labeling Rule of 1994 mandates that
A. | all drug trials include children after a drug has been fully tested on
adults. | B. | all drugs carry information for pediatric use based on studies of adults and other
pediatric treatment information. | C. | all drugs have pediatric dosing and safety
information on their labels if the drug has potential use for pediatric patients. | D. | all drug labels
indicated whether they have been tested on children. |
|
|
15.
|
After a patent has expired for a medication, other manufactures may copy the
drug and release it under the _______________ name.
A. | generic | B. | trade | C. | brand | D. | patent |
|
|
16.
|
Manufacturers of generic drugs
A. | need to perform the same safety and effectiveness testing required for new
drugs. | B. | do not need to perform the same safety and effectiveness testing but do need to
demonstrate that a drug is pharmaceutically equivalent to the corresponding propriety
drug. | C. | do not need to perform the same safety and effectiveness testing but do need to
demonstrate a drug is therapeutically equivalent to the corresponding proprietary
drug. | D. | do not need to perform the same safety and effectiveness testing but do need to
demonstrate that a drug is both pharmaceutically and therapeutically equivalent to the corresponding
proprietary drug. |
|
|
17.
|
Drugs that do not require a prescription are ___________________ drugs.
A. | FDA | B. | OTC | C. | Durham-Humphrey | D. | legend |
|
|
18.
|
The Combat Methamphetamine Epidemic Act requires that OTC cold and allergy
medications that contain which of the following drugs be kept behind the counter?
A. | antihistamine | B. | methamphetamine | C. | ephedrine and
pseudoephedrine | D. | antitussive |
|
|
19.
|
Pharmacy technicians may sell exempt narcotics
A. | without approval from the pharmacist if they record the sale in a record
book. | B. | only with approval from the pharmacist. | C. | after the pharmacist
has approved and documented the sale in the record book. | D. | without approval or
documentation of the sale. |
|
|
20.
|
A prescription to dispense Plan B®
A. | is not required. | B. | is required for patients under
17. | C. | is required for patients 17 years of age and under. | D. | is required for
patients 17 years of age and under unless otherwise allowed by state
law. |
|
|
21.
|
Of the following Schedule of drugs, which one deals with drugs that have no
accepted medical use in the United States?
A. | Schedule I | B. | Schedule II | C. | Schedule
III | D. | Schedule IV |
|
|
22.
|
Amphetamines, opium, cocaine, and methadone are in DEA schedule _________
because they have a high potential for abuse and may lead to physical or psychological
dependence.
|
|
23.
|
The FDA reporting system for adverse effects that occur from use of approved
drugs is called
A. | Class I. | B. | MedWatch. | C. | VAERS. | D. | Class II. |
|
|
24.
|
_____________________ drug recalls are issued by manufacturers when there us
strong likelihood that a product will cause serious adverse effects or death.
A. | Class I | B. | Class II | C. | Class
III | D. | Class IV |
|
|
25.
|
A technician could be prosecuted for misconduct called ______________ if s/he
incorrectly labeled a prescription.
A. | liability | B. | insubordination | C. | negligence | D. | compliance |
|
|
26.
|
Basic criminal and civil laws, like theft, discrimination, sexual harassment,
and fraud, apply to pharmacy technicians.
|
|
27.
|
Pharmacies located in the health care institutions (hospitals, etc) are required
to follow regulations of this organization:
|
Matching
|
|
|
Match the terms. A. | medications with habit-forming
ingredients that can be dispensed by a pharmacist without a prescription to persons at least 18 years
of age. | B. | any drug which requires a prescription and this “legend” on the
label: Rx only. | C. | failing to do something you should have
done. | D. | important associated information that is not on the label of a drug product
itself. | E. | legal responsibility for costs or damages arising from misconduct or
negligence. | F. | status of medications like Plan B® that are classified as both prescription and
OTC drugs. | G. | the action taken to remove a drug from the market and have it returned to the
manufacturer. | H. | the mark (CII-CV) which indicates the control category of a drug with a potential for
abuse. | I. | the number on a manufacturer’s label indicating the manufacturer and product
information. | J. | Federal law that sets daily and monthly limits on OTC sales of pseudoephedrine and
ephedrine. | K. | an inactive substance given in place of a medication. | L. | having to do with
treatment of children. | M. | drug products that contain identical amounts of
the same active ingredients in the same dosage. | N. | pharmaceutical equivalents that produce the
same effects in patients. | O. | five groups of drugs identified by the 1970
Controlled Substance Act (CSA) as having the potential for abuse and whose distribution is therefore
strictly controlled by five control schedules set forth in the CSA. | P. | an unintended side
effect of a medication that is negative or in some way injurious to a patient’s
health. | Q. | a court order preventing a specific action, such as the distribution of a potentially
dangerous drug. | R. | specific guidelines for practice. | S. | doing what is
required. |
|
|
28.
|
adverse effect
|
|
29.
|
Combat Methamphetamine Epidemic Act (CMEA)
|
|
30.
|
compliance
|
|
31.
|
controlled substance mark
|
|
32.
|
controlled substances
|
|
33.
|
dual marketing
|
|
34.
|
exempt narcotics
|
|
35.
|
injunction
|
|
36.
|
legend drug
|
|
37.
|
liability
|
|
38.
|
NDC (National Drug Code)
|
|
39.
|
negligence
|
|
40.
|
pediatric
|
|
41.
|
pharmaceutical equivalent
|
|
42.
|
placebo
|
|
43.
|
product labeling
|
|
44.
|
protocol
|
|
45.
|
recall
|
|
46.
|
therapeutic equivalent
|